Health news
Health news top Health news

   Login  |  Register    
Health News Make AMN Your Home PageDiscussion BoardsAdvanced Search ToolMedical RSS/XML News FeedHealth news
  You are here : Health.am > Health Centers > Heart Diseases Center > Heart Disease news

Long-term safety of drug-coated stents questioned

Heart Disease newsMar 17, 2010

New research shows more patients who got drug-coated stents right after suffering a heart attack later died from heart-related problems than those who received older, cheaper bare-metal stents.

Seven years after the first drug-coated stent was approved in the United States, cardiologists gathering in Atlanta for the American College of Cardiology meeting debated the issue, saying more research is needed to understand the long-term effects.

Danish researchers conducted a trial examining the effectiveness and risks of the two types of stents implanted right after heart attack.

They found that after three years, patients who got bare-metal stents were more likely to have problems, like requiring more intervention for blockages, while patients with the drug-coated variety were more likely to die from heart-related problems.

“The key message here is that we have shown that despite a finding of lower major adverse cardiac events, cardiac mortality was significantly higher in the drug-eluting stent group,” said Dr. Peter Clemmensen of Copenhagen University Hospital.

Stents are tiny tubular devices used to prop open diseased heart arteries and have been used widely for almost 20 years. Newer and more expensive versions of the devices are coated with anti-clotting drugs that keep treated arteries from reclogging.

When Johnson & Johnson released the first drug-coated stent in April 2003, it quickly became a big seller. The stent was considered to be revolutionary, and other medical device manufacturers raced to get their own versions on the market.

J&J, Medtronic Inc, Boston Scientific Corp and Abbott Laboratories Inc are the top manufacturers of stents and paid for the study by the Danish researchers.

---
By Debra Sherman and Bill Berkrot

ATLANTA (Reuters)

Provided by ArmMed Media

Email this to a friend Bookmark this! Printable Version

RELATED STORIES:


 Comments [ + Post Your Own

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]




We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.

All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

Please enter the word you see in the image below:


   [advanced search]   
Urology Problems and Information: Doctor-Reviewed Articles at UrologyToday.net


Health Centers

  Heart Attack

  Overview

  Causes

  Risk Factors

  Signs & Symptoms

  Diagnosis and Tests

  Treatment

  Prevention

  Follow-up

  Summary

  FAQ

  Conditions

  Angina

  Mitral stenosis

  Atrial Fibrillation

  Chest Pain

  Heart Failure

  Endocarditis

  Arrhythmias

  Atherosclerosis

  Heart disease Risk Factors

  Heart attack

  Coronary artery disease

  Coronary heart disease

  Congenital heart disease

  First aid - cardiac arrest

  Heart Surgery

  Myocardial Infarction

  Brady-tachycardia syndrome

  Anatomy of the Heart

» » »

Health Centers





Diabetes









Health news
  


Health Encyclopedia

Diseases & Conditions

Drugs & Medications

Health Tools

Health Tools



   Health newsletter

  





   Medical Links



   RSS/XML News Feed



   Feedback






Add to Google Reader or Homepage
Heart Diseases News, Headlines and Latest Stories on Health.am
Add to My AOL





Migraines and Headaches -Treatment & Care

hit counter